nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCB1—kidney cancer	0.0924	1	CbGaD
Mycophenolate mofetil—CES1—Capecitabine—kidney cancer	0.0695	0.125	CbGbCtD
Mycophenolate mofetil—UGT1A1—Pazopanib—kidney cancer	0.0331	0.0594	CbGbCtD
Mycophenolate mofetil—SLCO1B3—Paclitaxel—kidney cancer	0.0257	0.0461	CbGbCtD
Mycophenolate mofetil—UGT1A1—Erlotinib—kidney cancer	0.0236	0.0424	CbGbCtD
Mycophenolate mofetil—UGT1A9—Sorafenib—kidney cancer	0.0235	0.0421	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Pazopanib—kidney cancer	0.0229	0.0411	CbGbCtD
Mycophenolate mofetil—UGT1A1—Sorafenib—kidney cancer	0.0192	0.0344	CbGbCtD
Mycophenolate mofetil—CYP3A5—Temsirolimus—kidney cancer	0.0192	0.0344	CbGbCtD
Mycophenolate mofetil—ABCG2—Pazopanib—kidney cancer	0.0182	0.0327	CbGbCtD
Mycophenolate mofetil—ABCG2—Dactinomycin—kidney cancer	0.0166	0.0299	CbGbCtD
Mycophenolate mofetil—ABCC2—Paclitaxel—kidney cancer	0.0131	0.0236	CbGbCtD
Mycophenolate mofetil—ABCG2—Erlotinib—kidney cancer	0.013	0.0233	CbGbCtD
Mycophenolate mofetil—ABCB1—Temsirolimus—kidney cancer	0.0125	0.0224	CbGbCtD
Mycophenolate mofetil—ABCG2—Paclitaxel—kidney cancer	0.0119	0.0213	CbGbCtD
Mycophenolate mofetil—ABCC2—Sorafenib—kidney cancer	0.0117	0.021	CbGbCtD
Mycophenolate mofetil—ABCC2—Vinblastine—kidney cancer	0.0115	0.0207	CbGbCtD
Mycophenolate mofetil—ABCC2—Vincristine—kidney cancer	0.0113	0.0203	CbGbCtD
Mycophenolate mofetil—CYP3A4—Everolimus—kidney cancer	0.0111	0.0199	CbGbCtD
Mycophenolate mofetil—ABCG2—Sorafenib—kidney cancer	0.0106	0.0189	CbGbCtD
Mycophenolate mofetil—ABCG2—Vincristine—kidney cancer	0.0102	0.0184	CbGbCtD
Mycophenolate mofetil—CYP2C8—Pazopanib—kidney cancer	0.00969	0.0174	CbGbCtD
Mycophenolate mofetil—ABCC2—Sunitinib—kidney cancer	0.00946	0.017	CbGbCtD
Mycophenolate mofetil—ALB—Erlotinib—kidney cancer	0.00895	0.0161	CbGbCtD
Mycophenolate mofetil—ABCG2—Sunitinib—kidney cancer	0.00855	0.0154	CbGbCtD
Mycophenolate mofetil—CYP3A4—Temsirolimus—kidney cancer	0.00748	0.0134	CbGbCtD
Mycophenolate mofetil—CYP3A5—Erlotinib—kidney cancer	0.00719	0.0129	CbGbCtD
Mycophenolate mofetil—ABCC2—Doxorubicin—kidney cancer	0.00708	0.0127	CbGbCtD
Mycophenolate mofetil—CYP2C8—Erlotinib—kidney cancer	0.00692	0.0124	CbGbCtD
Mycophenolate mofetil—CYP3A5—Paclitaxel—kidney cancer	0.00658	0.0118	CbGbCtD
Mycophenolate mofetil—ABCB1—Pazopanib—kidney cancer	0.00656	0.0118	CbGbCtD
Mycophenolate mofetil—ABCG2—Doxorubicin—kidney cancer	0.00641	0.0115	CbGbCtD
Mycophenolate mofetil—CYP2C8—Paclitaxel—kidney cancer	0.00633	0.0114	CbGbCtD
Mycophenolate mofetil—ABCB1—Dactinomycin—kidney cancer	0.006	0.0108	CbGbCtD
Mycophenolate mofetil—CYP3A5—Sorafenib—kidney cancer	0.00585	0.0105	CbGbCtD
Mycophenolate mofetil—CYP3A5—Vincristine—kidney cancer	0.00568	0.0102	CbGbCtD
Mycophenolate mofetil—CYP2C8—Sorafenib—kidney cancer	0.00562	0.0101	CbGbCtD
Mycophenolate mofetil—ABCB1—Gemcitabine—kidney cancer	0.00474	0.00851	CbGbCtD
Mycophenolate mofetil—CYP3A5—Sunitinib—kidney cancer	0.00474	0.00851	CbGbCtD
Mycophenolate mofetil—ABCB1—Erlotinib—kidney cancer	0.00468	0.0084	CbGbCtD
Mycophenolate mofetil—ABCB1—Paclitaxel—kidney cancer	0.00429	0.00769	CbGbCtD
Mycophenolate mofetil—CYP3A4—Pazopanib—kidney cancer	0.00393	0.00706	CbGbCtD
Mycophenolate mofetil—ABCB1—Sorafenib—kidney cancer	0.00381	0.00683	CbGbCtD
Mycophenolate mofetil—ABCB1—Vinblastine—kidney cancer	0.00376	0.00675	CbGbCtD
Mycophenolate mofetil—UGT1A1—urine—kidney cancer	0.00371	0.0736	CbGeAlD
Mycophenolate mofetil—ABCB1—Vincristine—kidney cancer	0.0037	0.00663	CbGbCtD
Mycophenolate mofetil—UGT1A7—renal system—kidney cancer	0.00316	0.0626	CbGeAlD
Mycophenolate mofetil—ABCB1—Sunitinib—kidney cancer	0.00308	0.00554	CbGbCtD
Mycophenolate mofetil—UGT1A7—kidney—kidney cancer	0.00305	0.0605	CbGeAlD
Mycophenolate mofetil—CYP3A4—Erlotinib—kidney cancer	0.0028	0.00503	CbGbCtD
Mycophenolate mofetil—UGT1A10—renal system—kidney cancer	0.00264	0.0523	CbGeAlD
Mycophenolate mofetil—CYP3A4—Paclitaxel—kidney cancer	0.00257	0.00461	CbGbCtD
Mycophenolate mofetil—UGT1A10—kidney—kidney cancer	0.00255	0.0506	CbGeAlD
Mycophenolate mofetil—ABCB1—Doxorubicin—kidney cancer	0.00231	0.00415	CbGbCtD
Mycophenolate mofetil—CYP3A4—Sorafenib—kidney cancer	0.00228	0.00409	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vinblastine—kidney cancer	0.00225	0.00404	CbGbCtD
Mycophenolate mofetil—CYP3A4—Vincristine—kidney cancer	0.00221	0.00397	CbGbCtD
Mycophenolate mofetil—UGT1A8—renal system—kidney cancer	0.00209	0.0414	CbGeAlD
Mycophenolate mofetil—UGT1A8—kidney—kidney cancer	0.00202	0.04	CbGeAlD
Mycophenolate mofetil—CYP3A4—Sunitinib—kidney cancer	0.00185	0.00332	CbGbCtD
Mycophenolate mofetil—CYP3A4—Doxorubicin—kidney cancer	0.00138	0.00248	CbGbCtD
Mycophenolate mofetil—UGT1A9—renal system—kidney cancer	0.00132	0.0263	CbGeAlD
Mycophenolate mofetil—IMPDH2—nephron tubule—kidney cancer	0.00129	0.0256	CbGeAlD
Mycophenolate mofetil—UGT1A9—kidney—kidney cancer	0.00128	0.0254	CbGeAlD
Mycophenolate mofetil—CYP3A4—urine—kidney cancer	0.00119	0.0236	CbGeAlD
Mycophenolate mofetil—IMPDH2—renal system—kidney cancer	0.00118	0.0233	CbGeAlD
Mycophenolate mofetil—CES2—nephron tubule—kidney cancer	0.00117	0.0233	CbGeAlD
Mycophenolate mofetil—IMPDH1—renal system—kidney cancer	0.00117	0.0232	CbGeAlD
Mycophenolate mofetil—IMPDH2—kidney—kidney cancer	0.00114	0.0225	CbGeAlD
Mycophenolate mofetil—IMPDH1—kidney—kidney cancer	0.00113	0.0224	CbGeAlD
Mycophenolate mofetil—IMPDH2—cortex of kidney—kidney cancer	0.00111	0.0219	CbGeAlD
Mycophenolate mofetil—CES2—renal system—kidney cancer	0.00107	0.0212	CbGeAlD
Mycophenolate mofetil—UGT2B7—renal system—kidney cancer	0.00107	0.0212	CbGeAlD
Mycophenolate mofetil—IMPDH2—gonad—kidney cancer	0.00105	0.0209	CbGeAlD
Mycophenolate mofetil—IMPDH2—cardiac atrium—kidney cancer	0.00105	0.0209	CbGeAlD
Mycophenolate mofetil—CES2—kidney—kidney cancer	0.00103	0.0205	CbGeAlD
Mycophenolate mofetil—UGT2B7—kidney—kidney cancer	0.00103	0.0205	CbGeAlD
Mycophenolate mofetil—CES2—cortex of kidney—kidney cancer	0.00101	0.0199	CbGeAlD
Mycophenolate mofetil—CES2—gonad—kidney cancer	0.000958	0.019	CbGeAlD
Mycophenolate mofetil—CES2—cardiac atrium—kidney cancer	0.000956	0.019	CbGeAlD
Mycophenolate mofetil—UGT1A1—renal system—kidney cancer	0.000908	0.018	CbGeAlD
Mycophenolate mofetil—UGT1A1—kidney—kidney cancer	0.000878	0.0174	CbGeAlD
Mycophenolate mofetil—SLCO1B1—renal system—kidney cancer	0.000756	0.015	CbGeAlD
Mycophenolate mofetil—SLCO1B1—kidney—kidney cancer	0.000731	0.0145	CbGeAlD
Mycophenolate mofetil—ABCC2—nephron tubule—kidney cancer	0.00063	0.0125	CbGeAlD
Mycophenolate mofetil—ABCC2—renal system—kidney cancer	0.000573	0.0114	CbGeAlD
Mycophenolate mofetil—ABCC2—kidney—kidney cancer	0.000554	0.011	CbGeAlD
Mycophenolate mofetil—ABCC2—cortex of kidney—kidney cancer	0.000539	0.0107	CbGeAlD
Mycophenolate mofetil—ABCG2—nephron tubule—kidney cancer	0.00046	0.00911	CbGeAlD
Mycophenolate mofetil—CYP2C8—renal system—kidney cancer	0.00043	0.00852	CbGeAlD
Mycophenolate mofetil—CYP3A5—nephron tubule—kidney cancer	0.000427	0.00846	CbGeAlD
Mycophenolate mofetil—CYP2C8—kidney—kidney cancer	0.000415	0.00824	CbGeAlD
Mycophenolate mofetil—CYP3A5—renal system—kidney cancer	0.000388	0.00769	CbGeAlD
Mycophenolate mofetil—CYP3A5—kidney—kidney cancer	0.000375	0.00744	CbGeAlD
Mycophenolate mofetil—CYP3A5—cortex of kidney—kidney cancer	0.000365	0.00724	CbGeAlD
Mycophenolate mofetil—CYP3A4—renal system—kidney cancer	0.000291	0.00577	CbGeAlD
Mycophenolate mofetil—CYP3A4—kidney—kidney cancer	0.000281	0.00558	CbGeAlD
Mycophenolate mofetil—ABCB1—nephron tubule—kidney cancer	0.000227	0.00449	CbGeAlD
Mycophenolate mofetil—ABCB1—renal system—kidney cancer	0.000206	0.00409	CbGeAlD
Mycophenolate mofetil—ABCB1—kidney—kidney cancer	0.000199	0.00395	CbGeAlD
Mycophenolate mofetil—ABCB1—cortex of kidney—kidney cancer	0.000194	0.00385	CbGeAlD
Mycophenolate mofetil—ABCB1—gonad—kidney cancer	0.000185	0.00366	CbGeAlD
Mycophenolate mofetil—Dehydration—Doxorubicin—kidney cancer	3.51e-05	0.000172	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Paclitaxel—kidney cancer	3.51e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Oedema—Paclitaxel—kidney cancer	3.51e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Vincristine—kidney cancer	3.49e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Vincristine—kidney cancer	3.49e-05	0.000171	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Doxorubicin—kidney cancer	3.49e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Infection—Paclitaxel—kidney cancer	3.49e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Flatulence—Capecitabine—kidney cancer	3.48e-05	0.00017	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Capecitabine—kidney cancer	3.46e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Dizziness—Sunitinib—kidney cancer	3.46e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Gemcitabine—kidney cancer	3.46e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Shock—Paclitaxel—kidney cancer	3.45e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Vomiting—Sorafenib—kidney cancer	3.45e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Orthostatic hypotension—Doxorubicin—kidney cancer	3.45e-05	0.000169	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Paclitaxel—kidney cancer	3.44e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Doxorubicin—kidney cancer	3.44e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Paclitaxel—kidney cancer	3.44e-05	0.000168	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Paclitaxel—kidney cancer	3.43e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Rash—Sorafenib—kidney cancer	3.42e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Sorafenib—kidney cancer	3.42e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Back pain—Capecitabine—kidney cancer	3.41e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Paclitaxel—kidney cancer	3.41e-05	0.000167	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	3.4e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Headache—Sorafenib—kidney cancer	3.4e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Capecitabine—kidney cancer	3.39e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Paclitaxel—kidney cancer	3.39e-05	0.000166	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Dactinomycin—kidney cancer	3.39e-05	0.000165	CcSEcCtD
Mycophenolate mofetil—Anorexia—Paclitaxel—kidney cancer	3.35e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Gastritis—Doxorubicin—kidney cancer	3.34e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Doxorubicin—kidney cancer	3.33e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Doxorubicin—kidney cancer	3.33e-05	0.000163	CcSEcCtD
Mycophenolate mofetil—Vomiting—Sunitinib—kidney cancer	3.32e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Gemcitabine—kidney cancer	3.31e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Tremor—Capecitabine—kidney cancer	3.31e-05	0.000162	CcSEcCtD
Mycophenolate mofetil—Rash—Sunitinib—kidney cancer	3.3e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Sunitinib—kidney cancer	3.29e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Doxorubicin—kidney cancer	3.29e-05	0.000161	CcSEcCtD
Mycophenolate mofetil—Hypotension—Paclitaxel—kidney cancer	3.28e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Capecitabine—kidney cancer	3.28e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Headache—Sunitinib—kidney cancer	3.27e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Asthma—Doxorubicin—kidney cancer	3.27e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Influenza—Doxorubicin—kidney cancer	3.27e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Doxorubicin—kidney cancer	3.27e-05	0.00016	CcSEcCtD
Mycophenolate mofetil—Anaemia—Capecitabine—kidney cancer	3.26e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Vincristine—kidney cancer	3.26e-05	0.000159	CcSEcCtD
Mycophenolate mofetil—Nausea—Sorafenib—kidney cancer	3.23e-05	0.000158	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Doxorubicin—kidney cancer	3.2e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Paclitaxel—kidney cancer	3.2e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Malaise—Capecitabine—kidney cancer	3.18e-05	0.000156	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Doxorubicin—kidney cancer	3.18e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Insomnia—Paclitaxel—kidney cancer	3.18e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Vertigo—Capecitabine—kidney cancer	3.17e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Asthenia—Vincristine—kidney cancer	3.17e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Syncope—Capecitabine—kidney cancer	3.17e-05	0.000155	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Capecitabine—kidney cancer	3.16e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Paclitaxel—kidney cancer	3.15e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Vomiting—Dactinomycin—kidney cancer	3.15e-05	0.000154	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Doxorubicin—kidney cancer	3.14e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Paclitaxel—kidney cancer	3.13e-05	0.000153	CcSEcCtD
Mycophenolate mofetil—Somnolence—Paclitaxel—kidney cancer	3.12e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Palpitations—Capecitabine—kidney cancer	3.12e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Rash—Dactinomycin—kidney cancer	3.12e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Nausea—Sunitinib—kidney cancer	3.1e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Capecitabine—kidney cancer	3.1e-05	0.000152	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Doxorubicin—kidney cancer	3.1e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Paclitaxel—kidney cancer	3.09e-05	0.000151	CcSEcCtD
Mycophenolate mofetil—Cough—Capecitabine—kidney cancer	3.08e-05	0.00015	CcSEcCtD
Mycophenolate mofetil—Dysuria—Doxorubicin—kidney cancer	3.05e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Doxorubicin—kidney cancer	3.05e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Paclitaxel—kidney cancer	3.05e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Hypertension—Capecitabine—kidney cancer	3.05e-05	0.000149	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Paclitaxel—kidney cancer	3.03e-05	0.000148	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Vincristine—kidney cancer	3.02e-05	0.000148	CcSEcCtD
Mycophenolate mofetil—Pollakiuria—Doxorubicin—kidney cancer	3.02e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Asthenia—Gemcitabine—kidney cancer	3.01e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Chest pain—Capecitabine—kidney cancer	3.01e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Capecitabine—kidney cancer	3.01e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Myalgia—Capecitabine—kidney cancer	3.01e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Pain—Paclitaxel—kidney cancer	3e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Constipation—Paclitaxel—kidney cancer	3e-05	0.000147	CcSEcCtD
Mycophenolate mofetil—Anxiety—Capecitabine—kidney cancer	3e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.98e-05	0.000146	CcSEcCtD
Mycophenolate mofetil—Weight increased—Doxorubicin—kidney cancer	2.97e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Discomfort—Capecitabine—kidney cancer	2.97e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Pruritus—Gemcitabine—kidney cancer	2.97e-05	0.000145	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Doxorubicin—kidney cancer	2.95e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Doxorubicin—kidney cancer	2.95e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Capecitabine—kidney cancer	2.94e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Nausea—Dactinomycin—kidney cancer	2.94e-05	0.000144	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Doxorubicin—kidney cancer	2.93e-05	0.000143	CcSEcCtD
Mycophenolate mofetil—Dizziness—Vincristine—kidney cancer	2.92e-05	0.000143	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Doxorubicin—kidney cancer	2.91e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Infestation—Doxorubicin—kidney cancer	2.91e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Confusional state—Capecitabine—kidney cancer	2.91e-05	0.000142	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Paclitaxel—kidney cancer	2.89e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Oedema—Capecitabine—kidney cancer	2.88e-05	0.000141	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Paclitaxel—kidney cancer	2.87e-05	0.00014	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Gemcitabine—kidney cancer	2.87e-05	0.00014	CcSEcCtD
Mycophenolate mofetil—Renal failure—Doxorubicin—kidney cancer	2.86e-05	0.00014	CcSEcCtD
Mycophenolate mofetil—Infection—Capecitabine—kidney cancer	2.86e-05	0.00014	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Doxorubicin—kidney cancer	2.85e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Doxorubicin—kidney cancer	2.84e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—Jaundice—Doxorubicin—kidney cancer	2.84e-05	0.000139	CcSEcCtD
Mycophenolate mofetil—Shock—Capecitabine—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Doxorubicin—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Doxorubicin—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Capecitabine—kidney cancer	2.83e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Capecitabine—kidney cancer	2.82e-05	0.000138	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Capecitabine—kidney cancer	2.81e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Vomiting—Vincristine—kidney cancer	2.81e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Capecitabine—kidney cancer	2.8e-05	0.000137	CcSEcCtD
Mycophenolate mofetil—Sweating—Doxorubicin—kidney cancer	2.79e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Urticaria—Paclitaxel—kidney cancer	2.79e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Rash—Vincristine—kidney cancer	2.79e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Capecitabine—kidney cancer	2.79e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Vincristine—kidney cancer	2.78e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Haematuria—Doxorubicin—kidney cancer	2.78e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Paclitaxel—kidney cancer	2.78e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Paclitaxel—kidney cancer	2.78e-05	0.000136	CcSEcCtD
Mycophenolate mofetil—Headache—Vincristine—kidney cancer	2.77e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Doxorubicin—kidney cancer	2.75e-05	0.000135	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Doxorubicin—kidney cancer	2.75e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Anorexia—Capecitabine—kidney cancer	2.75e-05	0.000134	CcSEcCtD
Mycophenolate mofetil—Sinusitis—Doxorubicin—kidney cancer	2.73e-05	0.000133	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Doxorubicin—kidney cancer	2.72e-05	0.000133	CcSEcCtD
Mycophenolate mofetil—Hypotension—Capecitabine—kidney cancer	2.69e-05	0.000132	CcSEcCtD
Mycophenolate mofetil—Vomiting—Gemcitabine—kidney cancer	2.67e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Doxorubicin—kidney cancer	2.66e-05	0.00013	CcSEcCtD
Mycophenolate mofetil—Rash—Gemcitabine—kidney cancer	2.64e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Gemcitabine—kidney cancer	2.64e-05	0.000129	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Doxorubicin—kidney cancer	2.63e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Headache—Gemcitabine—kidney cancer	2.63e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Nausea—Vincristine—kidney cancer	2.63e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.62e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Doxorubicin—kidney cancer	2.62e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Doxorubicin—kidney cancer	2.61e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Doxorubicin—kidney cancer	2.61e-05	0.000128	CcSEcCtD
Mycophenolate mofetil—Insomnia—Capecitabine—kidney cancer	2.61e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Doxorubicin—kidney cancer	2.6e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Doxorubicin—kidney cancer	2.59e-05	0.000127	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Capecitabine—kidney cancer	2.59e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Paclitaxel—kidney cancer	2.59e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Doxorubicin—kidney cancer	2.58e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Doxorubicin—kidney cancer	2.58e-05	0.000126	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Doxorubicin—kidney cancer	2.57e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Capecitabine—kidney cancer	2.57e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Doxorubicin—kidney cancer	2.56e-05	0.000125	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Capecitabine—kidney cancer	2.54e-05	0.000124	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Doxorubicin—kidney cancer	2.52e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Asthenia—Paclitaxel—kidney cancer	2.52e-05	0.000123	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Capecitabine—kidney cancer	2.5e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Nausea—Gemcitabine—kidney cancer	2.49e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Capecitabine—kidney cancer	2.49e-05	0.000122	CcSEcCtD
Mycophenolate mofetil—Pruritus—Paclitaxel—kidney cancer	2.48e-05	0.000121	CcSEcCtD
Mycophenolate mofetil—Constipation—Capecitabine—kidney cancer	2.46e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—Pain—Capecitabine—kidney cancer	2.46e-05	0.00012	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Doxorubicin—kidney cancer	2.44e-05	0.000119	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Doxorubicin—kidney cancer	2.44e-05	0.000119	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Doxorubicin—kidney cancer	2.43e-05	0.000119	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Paclitaxel—kidney cancer	2.4e-05	0.000117	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Capecitabine—kidney cancer	2.37e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Doxorubicin—kidney cancer	2.37e-05	0.000116	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Capecitabine—kidney cancer	2.36e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Doxorubicin—kidney cancer	2.36e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Chills—Doxorubicin—kidney cancer	2.35e-05	0.000115	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Doxorubicin—kidney cancer	2.34e-05	0.000114	CcSEcCtD
Mycophenolate mofetil—Dizziness—Paclitaxel—kidney cancer	2.32e-05	0.000113	CcSEcCtD
Mycophenolate mofetil—Alopecia—Doxorubicin—kidney cancer	2.31e-05	0.000113	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Doxorubicin—kidney cancer	2.29e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—Urticaria—Capecitabine—kidney cancer	2.29e-05	0.000112	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Capecitabine—kidney cancer	2.28e-05	0.000111	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Capecitabine—kidney cancer	2.28e-05	0.000111	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Doxorubicin—kidney cancer	2.28e-05	0.000111	CcSEcCtD
Mycophenolate mofetil—Flatulence—Doxorubicin—kidney cancer	2.24e-05	0.00011	CcSEcCtD
Mycophenolate mofetil—Tension—Doxorubicin—kidney cancer	2.23e-05	0.000109	CcSEcCtD
Mycophenolate mofetil—Vomiting—Paclitaxel—kidney cancer	2.23e-05	0.000109	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Doxorubicin—kidney cancer	2.23e-05	0.000109	CcSEcCtD
Mycophenolate mofetil—Rash—Paclitaxel—kidney cancer	2.21e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Paclitaxel—kidney cancer	2.21e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—Nervousness—Doxorubicin—kidney cancer	2.21e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—Back pain—Doxorubicin—kidney cancer	2.2e-05	0.000108	CcSEcCtD
Mycophenolate mofetil—Headache—Paclitaxel—kidney cancer	2.2e-05	0.000107	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Doxorubicin—kidney cancer	2.19e-05	0.000107	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Capecitabine—kidney cancer	2.12e-05	0.000104	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Doxorubicin—kidney cancer	2.11e-05	0.000103	CcSEcCtD
Mycophenolate mofetil—Anaemia—Doxorubicin—kidney cancer	2.1e-05	0.000103	CcSEcCtD
Mycophenolate mofetil—Agitation—Doxorubicin—kidney cancer	2.09e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—Nausea—Paclitaxel—kidney cancer	2.09e-05	0.000102	CcSEcCtD
Mycophenolate mofetil—Asthenia—Capecitabine—kidney cancer	2.07e-05	0.000101	CcSEcCtD
Mycophenolate mofetil—Malaise—Doxorubicin—kidney cancer	2.05e-05	0.0001	CcSEcCtD
Mycophenolate mofetil—Vertigo—Doxorubicin—kidney cancer	2.04e-05	9.99e-05	CcSEcCtD
Mycophenolate mofetil—Syncope—Doxorubicin—kidney cancer	2.04e-05	9.97e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Capecitabine—kidney cancer	2.04e-05	9.96e-05	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Doxorubicin—kidney cancer	2.04e-05	9.95e-05	CcSEcCtD
Mycophenolate mofetil—Palpitations—Doxorubicin—kidney cancer	2.01e-05	9.82e-05	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Doxorubicin—kidney cancer	2e-05	9.77e-05	CcSEcCtD
Mycophenolate mofetil—Cough—Doxorubicin—kidney cancer	1.99e-05	9.7e-05	CcSEcCtD
Mycophenolate mofetil—Convulsion—Doxorubicin—kidney cancer	1.97e-05	9.63e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Capecitabine—kidney cancer	1.97e-05	9.63e-05	CcSEcCtD
Mycophenolate mofetil—Hypertension—Doxorubicin—kidney cancer	1.96e-05	9.6e-05	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Doxorubicin—kidney cancer	1.94e-05	9.46e-05	CcSEcCtD
Mycophenolate mofetil—Myalgia—Doxorubicin—kidney cancer	1.94e-05	9.46e-05	CcSEcCtD
Mycophenolate mofetil—Chest pain—Doxorubicin—kidney cancer	1.94e-05	9.46e-05	CcSEcCtD
Mycophenolate mofetil—Anxiety—Doxorubicin—kidney cancer	1.93e-05	9.43e-05	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.92e-05	9.4e-05	CcSEcCtD
Mycophenolate mofetil—Discomfort—Doxorubicin—kidney cancer	1.91e-05	9.35e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Capecitabine—kidney cancer	1.91e-05	9.31e-05	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Doxorubicin—kidney cancer	1.89e-05	9.26e-05	CcSEcCtD
Mycophenolate mofetil—Confusional state—Doxorubicin—kidney cancer	1.87e-05	9.15e-05	CcSEcCtD
Mycophenolate mofetil—Oedema—Doxorubicin—kidney cancer	1.86e-05	9.07e-05	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Doxorubicin—kidney cancer	1.86e-05	9.07e-05	CcSEcCtD
Mycophenolate mofetil—Infection—Doxorubicin—kidney cancer	1.85e-05	9.01e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Capecitabine—kidney cancer	1.83e-05	8.95e-05	CcSEcCtD
Mycophenolate mofetil—Shock—Doxorubicin—kidney cancer	1.83e-05	8.93e-05	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Doxorubicin—kidney cancer	1.82e-05	8.9e-05	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Doxorubicin—kidney cancer	1.82e-05	8.88e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Capecitabine—kidney cancer	1.82e-05	8.87e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Capecitabine—kidney cancer	1.81e-05	8.87e-05	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Doxorubicin—kidney cancer	1.81e-05	8.85e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Capecitabine—kidney cancer	1.8e-05	8.82e-05	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Doxorubicin—kidney cancer	1.8e-05	8.81e-05	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Doxorubicin—kidney cancer	1.8e-05	8.77e-05	CcSEcCtD
Mycophenolate mofetil—Anorexia—Doxorubicin—kidney cancer	1.77e-05	8.65e-05	CcSEcCtD
Mycophenolate mofetil—Hypotension—Doxorubicin—kidney cancer	1.74e-05	8.48e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Capecitabine—kidney cancer	1.71e-05	8.36e-05	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.69e-05	8.27e-05	CcSEcCtD
Mycophenolate mofetil—Insomnia—Doxorubicin—kidney cancer	1.68e-05	8.21e-05	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Doxorubicin—kidney cancer	1.67e-05	8.15e-05	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Doxorubicin—kidney cancer	1.66e-05	8.09e-05	CcSEcCtD
Mycophenolate mofetil—Somnolence—Doxorubicin—kidney cancer	1.65e-05	8.06e-05	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Doxorubicin—kidney cancer	1.63e-05	7.99e-05	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Doxorubicin—kidney cancer	1.61e-05	7.89e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.6e-05	7.83e-05	CcSEcCtD
Mycophenolate mofetil—Pain—Doxorubicin—kidney cancer	1.59e-05	7.76e-05	CcSEcCtD
Mycophenolate mofetil—Constipation—Doxorubicin—kidney cancer	1.59e-05	7.76e-05	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Doxorubicin—kidney cancer	1.53e-05	7.48e-05	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Doxorubicin—kidney cancer	1.52e-05	7.42e-05	CcSEcCtD
Mycophenolate mofetil—Urticaria—Doxorubicin—kidney cancer	1.48e-05	7.21e-05	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Doxorubicin—kidney cancer	1.47e-05	7.17e-05	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Doxorubicin—kidney cancer	1.47e-05	7.17e-05	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Doxorubicin—kidney cancer	1.37e-05	6.68e-05	CcSEcCtD
Mycophenolate mofetil—Asthenia—Doxorubicin—kidney cancer	1.33e-05	6.51e-05	CcSEcCtD
Mycophenolate mofetil—Pruritus—Doxorubicin—kidney cancer	1.31e-05	6.42e-05	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Doxorubicin—kidney cancer	1.27e-05	6.21e-05	CcSEcCtD
Mycophenolate mofetil—Dizziness—Doxorubicin—kidney cancer	1.23e-05	6e-05	CcSEcCtD
Mycophenolate mofetil—Vomiting—Doxorubicin—kidney cancer	1.18e-05	5.77e-05	CcSEcCtD
Mycophenolate mofetil—Rash—Doxorubicin—kidney cancer	1.17e-05	5.72e-05	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Doxorubicin—kidney cancer	1.17e-05	5.71e-05	CcSEcCtD
Mycophenolate mofetil—Headache—Doxorubicin—kidney cancer	1.16e-05	5.68e-05	CcSEcCtD
Mycophenolate mofetil—Nausea—Doxorubicin—kidney cancer	1.1e-05	5.39e-05	CcSEcCtD
Mycophenolate mofetil—SLCO1B3—Metabolism—ABCB1—kidney cancer	8.99e-06	9.43e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALDH1A1—kidney cancer	8.95e-06	9.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	8.9e-06	9.33e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PIK3CA—kidney cancer	8.82e-06	9.25e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ACY1—kidney cancer	8.82e-06	9.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—BCHE—kidney cancer	8.75e-06	9.18e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—BCHE—kidney cancer	8.75e-06	9.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IGF2—kidney cancer	8.75e-06	9.18e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—GSTM1—kidney cancer	8.73e-06	9.15e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SCARB1—kidney cancer	8.71e-06	9.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GPC3—kidney cancer	8.67e-06	9.09e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—SLC5A5—kidney cancer	8.65e-06	9.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SLC5A5—kidney cancer	8.65e-06	9.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PGK1—kidney cancer	8.63e-06	9.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC5A3—kidney cancer	8.63e-06	9.05e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS1—kidney cancer	8.63e-06	9.05e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PGK1—kidney cancer	8.58e-06	9e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC5A3—kidney cancer	8.58e-06	9e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTP1—kidney cancer	8.57e-06	8.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ACHE—kidney cancer	8.52e-06	8.94e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTT1—kidney cancer	8.52e-06	8.94e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CA9—kidney cancer	8.47e-06	8.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.47e-06	8.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—LDHB—kidney cancer	8.46e-06	8.88e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PSMD7—kidney cancer	8.46e-06	8.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CA2—kidney cancer	8.44e-06	8.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	8.43e-06	8.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—LDHB—kidney cancer	8.42e-06	8.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—IL2—kidney cancer	8.38e-06	8.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—SLC2A1—kidney cancer	8.35e-06	8.76e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—SLC2A1—kidney cancer	8.35e-06	8.76e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CYP1A1—kidney cancer	8.27e-06	8.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALAD—kidney cancer	8.22e-06	8.62e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	8.18e-06	8.58e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTGS2—kidney cancer	8.14e-06	8.53e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ABCB1—kidney cancer	8.11e-06	8.51e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	8.1e-06	8.49e-05	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PIK3CA—kidney cancer	8.07e-06	8.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SCARB1—kidney cancer	8.07e-06	8.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	8.04e-06	8.43e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ST3GAL2—kidney cancer	8.02e-06	8.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	8.02e-06	8.41e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—BCHE—kidney cancer	8.02e-06	8.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS1—kidney cancer	7.99e-06	8.38e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	7.96e-06	8.35e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC5A5—kidney cancer	7.92e-06	8.31e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—GSTM1—kidney cancer	7.88e-06	8.26e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDH1A1—kidney cancer	7.84e-06	8.22e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PSMD7—kidney cancer	7.83e-06	8.21e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	7.77e-06	8.15e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	7.76e-06	8.14e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—SLC2A1—kidney cancer	7.65e-06	8.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PGK1—kidney cancer	7.52e-06	7.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC5A3—kidney cancer	7.52e-06	7.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PDHB—kidney cancer	7.5e-06	7.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Biological oxidations—POMC—kidney cancer	7.48e-06	7.84e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CYP1A1—kidney cancer	7.47e-06	7.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—BCHE—kidney cancer	7.43e-06	7.79e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.42e-06	7.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—LDHB—kidney cancer	7.37e-06	7.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.37e-06	7.73e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CA9—kidney cancer	7.34e-06	7.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC5A5—kidney cancer	7.34e-06	7.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CA9—kidney cancer	7.3e-06	7.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.3e-06	7.65e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CRABP1—kidney cancer	7.2e-06	7.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.17e-06	7.52e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.13e-06	7.48e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	7.12e-06	7.47e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTEN—kidney cancer	7.1e-06	7.44e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—SLC2A1—kidney cancer	7.08e-06	7.43e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.06e-06	7.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CCBL1—kidney cancer	7.05e-06	7.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	7.01e-06	7.35e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTP1—kidney cancer	6.96e-06	7.3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTP1—kidney cancer	6.96e-06	7.3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—kidney cancer	6.86e-06	7.19e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.8e-06	7.13e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	6.76e-06	7.08e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	6.73e-06	7.06e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ITPR2—kidney cancer	6.7e-06	7.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	6.63e-06	6.95e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—kidney cancer	6.59e-06	6.91e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—kidney cancer	6.59e-06	6.91e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.47e-06	6.79e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	6.45e-06	6.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	6.41e-06	6.72e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—GSTM1—kidney cancer	6.4e-06	6.71e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—GSTM1—kidney cancer	6.4e-06	6.71e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CA9—kidney cancer	6.39e-06	6.7e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTP1—kidney cancer	6.38e-06	6.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	6.31e-06	6.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CRABP1—kidney cancer	6.24e-06	6.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CRABP1—kidney cancer	6.2e-06	6.51e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—POMC—kidney cancer	6.17e-06	6.47e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PPAT—kidney cancer	6.11e-06	6.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GLIPR1—kidney cancer	6.11e-06	6.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTT1—kidney cancer	6.11e-06	6.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ACHE—kidney cancer	6.11e-06	6.4e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1A1—kidney cancer	6.07e-06	6.36e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1A1—kidney cancer	6.07e-06	6.36e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—kidney cancer	6.04e-06	6.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.96e-06	6.25e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTP1—kidney cancer	5.91e-06	6.2e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—GSTM1—kidney cancer	5.86e-06	6.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ITPR2—kidney cancer	5.8e-06	6.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SCARB1—kidney cancer	5.78e-06	6.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ITPR2—kidney cancer	5.77e-06	6.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS1—kidney cancer	5.72e-06	6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—FH—kidney cancer	5.68e-06	5.96e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—APRT—kidney cancer	5.68e-06	5.96e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PSMD7—kidney cancer	5.61e-06	5.89e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—kidney cancer	5.59e-06	5.86e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—POMC—kidney cancer	5.57e-06	5.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	5.56e-06	5.83e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1A1—kidney cancer	5.56e-06	5.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	5.48e-06	5.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CRABP1—kidney cancer	5.44e-06	5.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTM1—kidney cancer	5.43e-06	5.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.35e-06	5.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GPC3—kidney cancer	5.34e-06	5.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—BCHE—kidney cancer	5.32e-06	5.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.32e-06	5.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.3e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTT1—kidney cancer	5.29e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ACHE—kidney cancer	5.29e-06	5.55e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTT1—kidney cancer	5.26e-06	5.52e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ACHE—kidney cancer	5.26e-06	5.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC5A5—kidney cancer	5.26e-06	5.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA2—kidney cancer	5.2e-06	5.45e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1A1—kidney cancer	5.15e-06	5.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—SLC2A1—kidney cancer	5.08e-06	5.32e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALAD—kidney cancer	5.07e-06	5.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ITPR2—kidney cancer	5.05e-06	5.3e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SCARB1—kidney cancer	5.01e-06	5.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—kidney cancer	5.01e-06	5.25e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.98e-06	5.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SCARB1—kidney cancer	4.98e-06	5.22e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS1—kidney cancer	4.96e-06	5.2e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ST3GAL2—kidney cancer	4.94e-06	5.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS1—kidney cancer	4.93e-06	5.17e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—kidney cancer	4.92e-06	5.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PSMD7—kidney cancer	4.86e-06	5.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PSMD7—kidney cancer	4.83e-06	5.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDH1A1—kidney cancer	4.83e-06	5.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—RAF1—kidney cancer	4.82e-06	5.05e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PGK1—kidney cancer	4.63e-06	4.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC5A3—kidney cancer	4.63e-06	4.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTT1—kidney cancer	4.61e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ACHE—kidney cancer	4.61e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—BCHE—kidney cancer	4.61e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—BCHE—kidney cancer	4.58e-06	4.8e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.57e-06	4.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC5A5—kidney cancer	4.55e-06	4.77e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—LDHB—kidney cancer	4.54e-06	4.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC5A5—kidney cancer	4.53e-06	4.75e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—POMC—kidney cancer	4.52e-06	4.74e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—POMC—kidney cancer	4.52e-06	4.74e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—kidney cancer	4.44e-06	4.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—SLC2A1—kidney cancer	4.4e-06	4.61e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—SLC2A1—kidney cancer	4.37e-06	4.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SCARB1—kidney cancer	4.36e-06	4.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS1—kidney cancer	4.32e-06	4.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—IL2—kidney cancer	4.32e-06	4.53e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTEN—kidney cancer	4.29e-06	4.5e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.27e-06	4.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.24e-06	4.45e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PSMD7—kidney cancer	4.24e-06	4.44e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTP1—kidney cancer	4.23e-06	4.44e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—RAF1—kidney cancer	4.17e-06	4.37e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—POMC—kidney cancer	4.14e-06	4.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—BCHE—kidney cancer	4.02e-06	4.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—kidney cancer	4.01e-06	4.2e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC5A5—kidney cancer	3.97e-06	4.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA9—kidney cancer	3.94e-06	4.13e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTM1—kidney cancer	3.89e-06	4.08e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTEN—kidney cancer	3.87e-06	4.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—POMC—kidney cancer	3.84e-06	4.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—SLC2A1—kidney cancer	3.83e-06	4.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.72e-06	3.9e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.7e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1A1—kidney cancer	3.69e-06	3.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—VEGFA—kidney cancer	3.67e-06	3.85e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTP1—kidney cancer	3.67e-06	3.85e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.65e-06	3.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTP1—kidney cancer	3.65e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—kidney cancer	3.61e-06	3.78e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—kidney cancer	3.61e-06	3.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK3—kidney cancer	3.47e-06	3.64e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—kidney cancer	3.47e-06	3.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—kidney cancer	3.45e-06	3.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTM1—kidney cancer	3.37e-06	3.53e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTM1—kidney cancer	3.35e-06	3.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CRABP1—kidney cancer	3.35e-06	3.51e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—kidney cancer	3.31e-06	3.47e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—MAPK1—kidney cancer	3.3e-06	3.46e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTP1—kidney cancer	3.19e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.19e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1A1—kidney cancer	3.18e-06	3.33e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTEN—kidney cancer	3.15e-06	3.3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTEN—kidney cancer	3.15e-06	3.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—KRAS—kidney cancer	3.12e-06	3.27e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ITPR2—kidney cancer	3.11e-06	3.27e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—kidney cancer	3.06e-06	3.21e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—kidney cancer	3.03e-06	3.17e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTM1—kidney cancer	2.94e-06	3.08e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTEN—kidney cancer	2.88e-06	3.02e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—kidney cancer	2.87e-06	3.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—kidney cancer	2.84e-06	2.98e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ACHE—kidney cancer	2.84e-06	2.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1A1—kidney cancer	2.78e-06	2.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—kidney cancer	2.77e-06	2.91e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—POMC—kidney cancer	2.75e-06	2.88e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—kidney cancer	2.73e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SCARB1—kidney cancer	2.69e-06	2.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTEN—kidney cancer	2.67e-06	2.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS1—kidney cancer	2.66e-06	2.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.62e-06	2.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.61e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PSMD7—kidney cancer	2.61e-06	2.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BCHE—kidney cancer	2.47e-06	2.59e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.44e-06	2.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—POMC—kidney cancer	2.38e-06	2.5e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—POMC—kidney cancer	2.37e-06	2.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.36e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—kidney cancer	2.22e-06	2.33e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—kidney cancer	2.22e-06	2.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—kidney cancer	2.19e-06	2.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—POMC—kidney cancer	2.07e-06	2.18e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—kidney cancer	2.03e-06	2.13e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTP1—kidney cancer	1.97e-06	2.06e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTEN—kidney cancer	1.91e-06	2.01e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—kidney cancer	1.9e-06	1.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—kidney cancer	1.89e-06	1.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—kidney cancer	1.88e-06	1.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—kidney cancer	1.86e-06	1.95e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTM1—kidney cancer	1.81e-06	1.9e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.71e-06	1.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTEN—kidney cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—kidney cancer	1.66e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTEN—kidney cancer	1.65e-06	1.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTEN—kidney cancer	1.44e-06	1.51e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.35e-06	1.41e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—POMC—kidney cancer	1.28e-06	1.34e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.17e-06	1.23e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.22e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—kidney cancer	1.02e-06	1.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—kidney cancer	1.02e-06	1.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTEN—kidney cancer	8.89e-07	9.32e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—kidney cancer	6.27e-07	6.58e-06	CbGpPWpGaD
